Patient Capital Management
Patient Capital Management reported 39 stocks worth $3B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are RPRX (6.7%), C (6.5%) and GOOGL (6.2%). Compared with Q1 2026, the fund opened new positions in GPN and GENI, added to UNH, AMZN and NCLH, trimmed RPRX, C and GOOGL and sold out of IBIT.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  RPRX Royalty Pharma PLC | $202M | 6.7% | 3.6M | −45K (−1%) | 8 of 8 | |
| 2 |  C Citigroup Inc | $196M | 6.5% | 1.4M | −10K (−1%) | 8 of 8 | |
| 3 |  GOOGL Alphabet Inc | $188M | 6.2% | 526K | −8,243 (−2%) | 8 of 8 | |
| 4 |  UNH Unitedhealth Group Inc | $182M | 6.0% | 438K | +632 (+0%) | 5 of 8 | |
| 5 |  AMZN Amazon Com Inc | $162M | 5.4% | 681K | +27K (+4%) | 8 of 8 | |
| 6 |  NVDA Nvidia Corporation | $142M | 4.7% | 710K | −1,528 (−0%) | 8 of 8 | |
| 7 |  CVS Cvs Health Corp | $128M | 4.3% | 1.2M | −122K (−9%) | 8 of 8 | |
| 8 |  NCLH Norwegian Cruise Line Hldg L | $127M | 4.2% | 6M | +280K (+5%) | 8 of 8 | |
| 9 |  QXO Qxo Inc | $123M | 4.1% | 7.1M | +358K (+5%) | 8 of 8 | |
| 10 |  ET Energy Transfer L P LP | $116M | 3.9% | 6.1M | −7,525 (−0%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 IBIT Ishares Bitcoin Trust ETF | $42.3M | 1.1M |
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 BIIB Biogen Inc | Call | $40.9M | 189K | +187,506 |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Patient Capital Management 13F FAQ
What does Patient Capital Management own?
Patient Capital Management reported 39 stocks worth $3B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are RPRX (6.7%), C (6.5%) and GOOGL (6.2%). The table above lists every position in the filing (the top 10 without an account).
What did Patient Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 2 new positions, 10 added to, 22 trimmed and 1 sold out. New positions include GPN and GENI. It sold all of IBIT.
When will Patient Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Patient Capital Management's portfolio worth?
The Q2 2026 filing reports $3B in US stocks ($3.1B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.